RXRX - Royalty Pharma expands Evrysdi royalty deal with PTC Therapeutics
2023-10-19 08:31:42 ET
More on PTC, Roche, etc.
- Recursion Pharmaceuticals: Wet Lab Meets Silicon, A Tale Of Two Bottom Lines
- Roche: Positive Readouts From Pipeline
- Roche: 2023 Should Mark The Bottom
- Roche slips after in-line Q3 sales
- Roche in pact with Monte Rosa to develop cancer and neuro drugs
For further details see:
Royalty Pharma expands Evrysdi royalty deal with PTC Therapeutics